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ABSTRACT OF THE THESIS 
Investigation of 89Zr-Siderophores as Molecular Imaging Agents for Positron Emission Tomography 
Imaging of Bacterial Infections 
by 
Nora Catharina Mary Goscinski 
Master of Arts in Chemistry 
Washington University in St. Louis, 2015 
Professor Suzanne E. Lapi, Chair 
 
Siderophores are small molecules synthesized by bacteria to harvest Fe3+ from their 
environment.  In infection scenarios, their production can increase infection virulence by increasing the 
ability of bacteria to obtain Fe3+ and therefore grow more rapidly.  The selective uptake of siderophores 
in vivo in multi-bacteria environments indicates that this class of molecules has a potential use as 
selective imaging agents.  In this work, DFO-NCS and a library of trihydroxamate siderophores were 
evaluated as vehicles to deliver 89Zr selectively to bacteria for Positron Emission Tomography (PET) 
imaging of bacterial infections. 
 
Productive work with radiometals involves thorough knowledge of the element’s chemistry as 
well as the sources and detrimental effects of any contaminating metal ions present with the radiometal 
in the reaction mixture.  As a case study to determine the factors likely to interfere with the 
complexation of any given radiometal, the quality control assay used to determine effective specific 
activity (ESA) of 64Cu was intensely examined.  The purpose of this study was to identify sources of 
 ix 
 
cold metal contaminants in the 64Cu production process and to identify which of those metals interfere 
with the binding of 64Cu to the TETA chelator.  The TETA titration method for determining 64Cu ESA 
has relative standard deviations of 27.6% and 40.3% for repeatability and reproducibility respectively 
and the chelator TETA is selective for picomolar amounts of Cu2+ in the presence of low millimolar 
concentrations of Zn2+ and Ni2+.  
 
When the 89Zr-DFO-NCS complex was tested against a panel of cell types, the uptake by human 
cells (SKBR3), Staphylococcus aureus cells, and Pseudomonas aeruginosa cells was significantly 
different (p<0.0001) and highest for S. aureus.  The Zr chemistry and bacterial uptake behavior of a 
library of trihydroxamate siderophores was then evaluated and compared to that of DFO-NCS.  The 
uptake of 89Zr-DFO-NCS and a siderophore library member (89Zr-V-129) were tested in a murine lung 
infection model (P. aeruginosa, PA M57-15) and the lung uptake of 89Zr-V-129 was found to be 
significantly higher in infected mice (p=0.012035) than in control mice. The uptake of 89Zr-DFO-NCS 
did not differ significantly between control and infected mice (p=0.831).  89Zr-siderophores have been 
shown to possess potential to be selective, specific PET tracers for imaging bacterial infections in vivo 
and their utility for infection imaging should be more thoroughly explored.     
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Chapter 1: Introduction to Radiochemistry  
While all chemists are familiar with the periodic table, which organizes the known elements by 
proton number and similarity of chemical behavior, nuclear and radiochemists have an additional 
reference available to them, the chart of the nuclides (figure 1-1, below).  The chart of the 
nuclides can be thought of as an extended periodic table, where each box represents a single 
nucleus rather than the average elemental mass presented in each box of the periodic table. 
Proton number is plotted in the y-direction, neutron number in the x-direction, and a third 
quantity (mass) can be imagined to be plotted along the z-axis.  The nucleus with lowest mass 
along an isobar (white arrow) is the most stable.   The valley of stability (black boxes) runs 
approximately through the center of the nuclides, but bends ‘south’ as neutron number increases. 
 
Figure 1: The Chart of the Nuclidesa 
 
   
                                                 
a https://www-nds.iaea.org/relnsd/vcharthtml/VChartHTML.html 
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1.1 Types of Radioactive Decay 
Unstable nuclei undergo radioactive decay when the daughter nucleus has a higher binding 
energy per nucleon than the parent nucleus [2].  Stated another way, a nucleus will undergo a 
particular mode of radioactive decay if the sum of the masses of particles after the decay is less 
than the initial mass of the unstable nucleus [2, 3].  However, nuclei may achieve this goal by a 
variety of routes.  The three main modes of radioactive decay are alpha, beta (β- ,β+, or electron 
capture) and gamma emission.  Although fission is a route by which certain unstable nuclei may 
reach stability, it will not be discussed in this work.   
1.1.1 Alpha Decay 
When a nucleus undergoes alpha decay, the parent nucleus ejects a helium nucleus (2 protons, 2 
neutrons), also known as an alpha particle [2].    
𝑃𝑜 →  𝐻𝑒 +  𝑃𝑏82
206
2
4
84
210             (1) 
The ejected α particle travels until it acquires 2 electrons and becomes an uncharged He atom.  
With a few key exceptions (such as 8Be), nuclei that decay via alpha particle emission tend to be 
rather massive (A≥208 [3]) and are found at the upper end of the chart of the nuclides (high-Z, 
high-A nuclei) (figure 1-1).   
1.1.2 Beta Decay 
Most nuclei decay via one of the three modes of beta particle emission [2, 4].  Typically, nuclei 
below the valley of stability decay via β- emission[2, 3].  In this decay mode, a neutron in the 
nucleus decays to a proton, an electron and an anti-neutrino: 
𝑌39
90 →  𝑍𝑟 + 𝛽− + 𝜈40
90               (2) 
  The daughter nucleus ejects the electron and anti-neutrino and these ejecta travel until the 
electron is moving slowly enough to be incorporated into an atomic electron cloud.  The anti-
neutrino interacts minimally with matter and travels great distances.     
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Nuclei above the valley of stability decay are proton-rich and therefore decay via β+ emission or 
electron capture.  In β+ emitting nuclei, a proton decays to a neutron, as well as a positron (β+, the 
anti-matter of the electron) and a neutrino [2, 3]: 
 
𝑍𝑟 →  𝑌39
89 + 𝛽+ + 𝜈40
89            (3) 
 
As in β- decay, the daughter nucleus ejects the leptons, in this case the positron and neutrino.  
However, once the β+ has lost sufficient energy to be captured, it is captured by an ordinary 
electron [3].  The captured β+ may form a neutral complex (known as Positronium, Ps) with the 
capturing electron, or may immediately undergo annihilation [2].  The Ps complex is very short-
lived and the β+ and e- soon annihilate one another, producing two γ photons (511 keV each) at 
~180⁰ relative to each otherb [2, 3].  These two coincident photons are the basis of the nuclear 
imaging technique Positron Emission Tomography (PET, see section 1.3.3) [2, 3, 5].  
 
A third mode of β decay, known as electron capture, occurs when the nucleus captures a low-
energy atomic electron, transforming a proton into a neutron [2, 3].  Nuclei undergoing electron 
capture decay lie above the line of stability, but lack sufficiently large Q values (mass difference 
between nuclei on an isobar) to undergo positron decay [2].    
                                                 
b The angle between annihilation photons is not always precisely 180 degrees but this work 
makes the assumption that any variation in this angle is too small to drastically alter any results 
obtained from the study of positron-emitting nuclides in vivo.   
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1.1.3  Gamma Decay  
Immediately after a nucleus decays by α or β emission, the daughter nucleus typically exists in a 
highly excited state [2, 3].  This excited daughter then relaxes to a lower-energy ground state via a 
variety of modes.  Electromagnetic radiation is released from the daughter nucleus as a result of 
this relaxation.  Such radiation originating from the nucleus is known as gamma (γ) radiation [2].  
While γ emission does not result in a new element, it does result in a more stable nucleus.  Often, 
the γ is emitted extremely close in time to the β decay event, but a few nuclides exist in which 
the emission of γ radiation by the excited daughter nucleus is delayed by minutes to hours [2].  
These long-lived excited daughters are known as metastable isomers of a nuclide [2] and can be 
isolated from the parent material for use in applications requiring photons, such as medical 
imaging.  A metastable isomer commonly used in medicine is 99mTc[4, 5], used in single photon 
emission computed tomography (SPECT)[4], which is produced according to the following 
(simplified) scheme: 
 
𝑀𝑜 →  𝛽− + 𝑇𝑐43
99𝑚 →  𝑇𝑐 + 𝛾 (140 𝑘𝑒𝑉)43
99
42
99         (4)c 
 
The 140 keV γ photons given off by the relaxation of 99mTc to 99Tc can be used to image disease 
within the body if attached to a suitable pharmaceutical [4, 5]. 
 
1.2 Production of Radioisotopes 
There are two main routes by which radioisotopes are produced for research and clinical 
applications.  Nuclei formed by neutron bombardment of the parent nucleus may be produced in 
                                                 
c 99Mo is typically produced by the fission of 235U in nuclear reactors.   
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nuclear reactors, while nuclides formed by proton bombardment of parent material may be 
produced using particle accelerators [2].   
1.2.1  Nuclear Reactors  
Nuclear reactors consist of rods of fissile uranium fuel (235U) immersed in a neutron-slowing 
medium such as water or graphite (see figure 1-2 for a schematic of a research reactor, below). 
 
Figure 1-2:  A typical “swimming pool” research reactor (a TRIGA IPR-R1) [6] 
The fuel is arranged in a manner allowing a self-sustaining chain fission reaction to occur in a 
controllable manner [2, 3, 5].  Samples of the target material are typically sealed in quartz vials [2] 
and immersed in the reactor where they are bombarded by the sea of thermalized (slow) neutrons 
[2].  The capture cross section of the target nucleus is maximized at low average energies of 
incident neutrons, so ‘slow’ neutrons are most likely to induce nuclear reactions and transmute 
the parent into a daughter nucleus.   
Because both parent and daughter have the same number of protons, the daughter is chemically 
identical to the parent material.  This can make isolation of the pure daughter nucleus difficult, as 
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the parent and daughter can only be separated by physical methods, rather than by chemical 
means.  Therefore, neutron irradiation in a nuclear reactor typically produces daughter nuclides 
with low specific activity (amount of radioactivity per unit mass) since large amounts of parent 
material remain with the daughter nuclide.   
However, there are some cases (such as the production of 111Ag from 110Pd [7, 8]) in which the 
daughter formed by neutron bombardment is short-lived and decays via to a longer-lived, 
chemically distinct grand-daughter nuclide, allowing isolation of the 111Ag with high specific 
activity.  Radionuclides produced via neutron irradiation in nuclear reactors tend to lie below the 
valley of stability.   
1.2.2 Accelerators 
Isotopes produced via bombardment of a parent nucleus with charged particles may be produced 
in particle accelerators [2, 3].  While linear accelerators may be used to irradiate target materials 
[2], in practice most radioisotopes for biomedical imaging studies are produced in cyclotrons, 
which are more space-efficient [5].  A typical cyclotron is shown in figure 1-3, below.   
 
Figure 1-3:  Cyclotron for production of radionuclidesd 
                                                 
d http://www.daviddarling.info/encyclopedia/C/cyclotron.html 
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An ion source produces charged particles for acceleration; while these may be either cations or 
anions, a given machine will only use one.  Under the influence of an electric field, the ions 
(typically H-) move from the ion source to the electromagnets of the machine, where their path is 
curved by a magnetic field.  When the ions reach the gap between the “dees” (charged plates 
between magnets), the electric field is reversed, accelerating the ions across the gap between 
dees [2, 5].  After this acceleration, the H- have a higher energy and traverse a path longer than 
their original route within the dee, until they reach the gap between dees again.  This process 
continues until the ions have achieved some maximum energy (dependent on the strength of the 
magnetic field and radius of the electrodes)[2, 4, 5].  When the H- cannot be accelerated any 
further, they are routed through a stripper foil (to remove electrons and convert H- to H+), after 
which they curve out of the dee structure.  The H+ then bombard  the target, reacting with nuclei 
and transmuting target nuclei into chemically distinct product nuclei[2].  Typically, this initial 
product nucleus is an extremely short-lived compound nucleus that evaporates at least one 
nucleon in order to achieve a more stable configuration of protons and neutrons[4].  It is this final 
product nucleus that is isolated from the target after irradiation.  Radionuclides of medical 
interest produced by this method include 18F, 64Cu, 89Zr, and 11C (Table 1-1) 
Table 1-1: Commonly used medical radionuclides and their production methods 
Radionuclide Production Reaction 
18F 𝑂8
18 (𝑝, 𝑛) 𝐹9
18   [9] 
11C 𝑁(𝑝, 𝛼) 𝐶6
11
7
14  [10] 
64Cu 𝑁𝑖(𝑝. 𝑛) 𝐶𝑢29
64
28
64  [11, 12] 
89Zr 𝑌(𝑝, 𝑛) 𝑍𝑟40
89
39
89  [13] 
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Radionuclides produced by charged particle irradiation typically lie above the valley of stability.  
They may decay by β+ or EC emission, depending on the parent nucleus irradiated.   
1.2.3  Comparison of Methods  
Target irradiations in accelerators and in reactors are complementary methods of radionuclide 
production.  As positron emission only occurs in nuclei above the line of stability, isotopes used 
in PET are produced on charged-particle accelerators[5].  However, nuclei below the line of 
stability are usually produced in nuclear reactors and these nuclides are often crucial for imaging 
and radiotherapy.  The most commonly used isotope in nuclear medicine (99mTc) is produced 
from a reactor-derived parent (99Mo).    
1.3  Molecular Imaging 
Molecular imaging can be defined as the study and application of molecules and machinery that 
permit non-invasive examination of biological processes in living organisms, rather than mere 
structural information[14].  While the most obvious application of molecular imaging is in the 
diagnosis and monitoring of disease, it can also be used to examine healthy biological systems.  
At its heart, molecular imaging is the quest to “see” specific chemical and biological processes 
and act on the information gleaned from said observation.   
1.3.1 Glossary 
To simplify the discussion, the following definitions will be used throughout this work: 
Tracer:  An entity, usually a molecule, that can be introduced to a living system and whose 
movement within that living system can be observed non-invasively.   
Beacon:  The part of the tracer responsible for the signal observed from outside the subject.  For 
example,  it may be a colored or fluorescent dye, a magnetically active metal ion or a radioactive 
atom.   
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Targeting moiety:  The part of the tracer that binds to a specific biological structure or causes the 
tracer as a whole to behave in a particular manner. 
1.3.2  The Tracer Principle 
While not true for all imaging modalities, many molecular imaging techniques rest on a 
statement known as “the tracer principle”.  In its simplest form, this principle states that 
molecules used to probe biological systems do not perturb the system under observation 
provided the tracer concentration is sufficiently low.  Furthermore, it assumes that molecules 
altered to be detectable through non-invasive methods (tracers) behave in a biologically identical 
manner to the unaltered molecules [2, 5].  This assumption is not strictly true, but in some imaging 
modalities, the difference between labeled and unlabeled tracer behavior is so small it can 
effectively be ignored[5].       
1.3.3  Positron Emission Tomography 
One of these methods is Positron Emission Tomography (PET).  PET relies on detection of the 
coincident 511 keV γ photons produced by the annihilation of a β+ with an ordinary electron[2].  
Tracers used for this imaging modality must therefore contain atoms which decay via β+ 
emission.  The operating principle of a typical PET scanner is shown below, in figure 1-4.  When 
two detectors in the ring detect an event simultaneously, the event is tagged as a coincidence 
event, and the tracer is assumed to lie along the line between the two detectors [2] (known as the 
line of response, LOR).  Detection of many LOR’s allows the exact location of the tracer within 
the system (typically a human patient) to be determined [5].   
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Figure 1-4: Positron Emission Tomography apparatus
e 
PET is a very sensitive technique [15].  The concentration of contrast agent in the body is usually 
10−12 mols/L or lower after injection [16, 17], so it does not measurably perturb the biological 
functions observed via PET.  Additionally, the beacon attached to the targeting moiety is 
extremely small (a single atom), so it is unlikely to alter the tracer’s pharmacokinetic behavior in 
vivo.  Because radioactivity is the signal monitored in PET, nearly background-free 
measurements are possible as essentially no positron-emitting nuclides are naturally present in 
the bodyf .  Background-free images are easier to interpret, since any signal present is from the 
administered tracer, rather than from an endogenous entity.  Finally, PET is a functional imaging 
modality, rather than an anatomical one.  Instead of showing what tissues and structures are 
present, PET scans present information about the chemical and biological state of the system 
imaged [5].  Thus, chemical pathways specific to the target can be probed and information about 
processes occurring in the system can be obtained.     
                                                 
e Source http://www.tnw.tudelft.nl/en/about-faculty/departments/radiation-science-technology/research/particle-
therapy/turning-the-physical-advantages-of-protons-into-true-clinical-benefits-with-in-beam-tof-pet/ 
 
f The exception is 40K, which has a β+ fraction of 1.0𝑥10−3 % and a half-life of 1.25𝑥109 years [17]. 
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1.3.4  Representative PET Isotopes 
The PET isotopes in most common clinical use are 18F and 11C [4].  These nuclides are commonly 
incorporated into the structure of small organic molecules such as glucose (making [18F]FDG).  
These tracers have short biological half-lives (due to their small size), and many have high-
abundance targets in vivo, making the relatively short-lived 18F and 11C ideal candidates for 
radiolabeling.   Both 11C [19] and 18F [20] emit low energy β+ particles with no γ emissions other 
than the annihilation photons, giving rise to clear PET images with minimal radiation dose to the 
patient.     
However, many imaging targets, e.g., cancer-specific receptors, are found in far lower abundance 
in the body than glucose transport proteins and require tracers with longer blood circulation 
times, such as monoclonal antibodies.  Tracers with long biological t1/2 require radiolabeling with 
longer-lived nuclides, so useful information may be extracted from imaging with these 
compounds [13].  Many of the longer-lived PET isotopes are radiometals.  Emerging radiometals 
include 64Cu[11, 12, 21-32] and 89Zr [13, 32-43], both of which have been used to label antibodies (and 
other tracer types) and image disease within the human body. 
1.3.5  Medical Uses of PET Tracers 
The most common clinical use of PET is to examine global glucose uptake in patients[46].  
Elevated glucose uptake is known to occur in diseased sites within a patient.  Hypermetabolic 
cells (which take up more glucose than their neighbors) may be inflamed, infected or cancerous 
(the Warburg effect) [47-49].  A PET scan with [18F]FDG will detect many of these pathologies[46].  
However, [18F]FDG cannot distinguish among the various conditions that underlie the increased 
glucose utilization of pathological cells[50].  There is a need to develop higher-specificity tracers 
that are taken up by narrow ranges of diseased cell types.   
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A novel use of PET that has been gaining attention in recent years is for imaging bacterial 
infections.  The dynamics of bacterial infections and possible imaging targets specific to this 
disease type will be discussed in further chapters of this work.   
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Chapter 2: Bacterial Infections  
2.1 Why Image Bacterial Infections? 
The current diagnostic paradigm for patients appearing to have bacterial infections is time-
consuming, requiring samples from the patient to be cultured for hours to weeks before enough 
bacteria are isolated to run destructive diagnostic tests [1].  The disease-causing bacteria are then 
usually identified through a combination of their growth requirements, dye uptake and enzymatic 
assays (such as whether the culture produces catalase)[1] (figure 2-1).  Because proper 
identification of the disease often takes a long time and bacterial infections tend to progress 
rapidly (e.g., Yersinia pestis infections are fatal in 3-5 days if left untreated [1]), more-rapid 
diagnostic techniques would allow physicians to identify what types of antimicrobial therapy 
would help a patient in a clinically-relevant timeframe. 
 
Figure 2-1:  Typical identification of an unknown bacterium from clinical sample (adapted from [51]) 
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The ability to image bacterial disease and identify the pathogen from imaging results would 
permit rapid, specific diagnosis of infection (as opposed to some other disorder causing illness) 
with a particular infectious agent.  Identifying the bacterium causing a patient’s disease would 
allow clinicians to administer narrow-spectrum antibiotics targeted at the pathogen, eliminating 
disease without also killing off “innocent bystanders” or potentially contributing to the rise of 
drug-resistant bacterial strains [1, 2].  Additionally, the ability to specifically image infections 
would allow long-term monitoring of infection progress and patient response to therapy, 
allowing clinicians to determine whether a treatment is truly curing a patient’s disease or merely 
alleviating its symptoms.   
2.2 The Role of Iron in Infection Dynamics 
In humans, the Fe3+ ion is used as a co-factor in a variety of proteins and enzymes [3-5].  The 
common biological use of iron is as an oxygen carrier in hemoglobin and myoglobin.  However, 
Fe is also used as a redox center by cytochrome proteins in the electron transport chain, which is 
responsible for most of a cell’s ATP production, as well as in the enzyme holo-aconitase in the 
TCA cycle [5, 6].  Fe is also involved in cellular signaling, via the NO signal transduction 
pathway[3].   
 
Bacteria likewise also require iron to carry out basic life processes, such as ATP synthesis.  The 
bacterial electron transport chain uses cytochrome proteins with iron redox centers [7] and certain 
anaerobic bacteria can use Fe3+ as a terminal electron acceptor [7].  Additionally, iron is used as a 
redox cofactor for processes such as nucleotide synthesis [7, 8].   
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Iron availability is a crucial determinant of bacterial virulence [4, 7, 9].  Bacterial cells need to 
obtain iron from their environment in order to grow and divide within the host, to form biofilms 
and to lyse host cells, among other activities associated with virulence [1, 7, 10].   
 
Because iron is so crucial to proper cellular function in both humans and bacterial cells, the 
human body has many systems to control the movement and use of iron [4, 9, 11].  Bacteria have 
evolved iron-harvesting systems that attempt to evade or outwit the host’s attempt to withhold 
iron from invading cells [4, 7, 10-12].  Consequently, the ability of a bacterium to obtain iron from 
its environment is crucial to the successful establishment of infection.   
2.3 Host Response to Infection 
The human host’s response to invasion by bacteria has two components.  The innate immune 
system controls the pathways that are constitutively “on”, while other portions are only activated 
in response to inflammation or infection-specific stimuli (such as the expression of particular 
cytokines, or pathogen-synthesized molecules) [1, 9].  A key strategy of both components of the 
immune response is to withhold iron from the infectious agent [4].   
2.3.1  Constitutive Iron Sequestration  
Iron in use in vivo is enclosed within many layers of biochemical structures [4, 6, 13].  For example, 
the Fe3+ used to carry O2 in the blood is not merely complexed by heme.  Heme groups nestle 
inside hemoglobin, and many units of hemoglobin are contained within each erythrocyte (red 
blood cell) [6, 13].   Therefore, many systems must fail before the Fe3+ ion is found in the blood.  
When erythrocytes die or are lysed, additional proteins are recruited to sequester the iron [4, 6, 10-
13].  Free hemoglobin is complexed by haptoglobin and the resulting complex is shuttled to the 
spleen for recycling [10, 14].  Likewise, if heme is found outside hemoglobin, a protein called 
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hemopexin complexes the Fe-porphyrin ring and shuttles it to the reticuloendothelial system for 
recycling [10-11].   
 
If Fe3+ manages to escape from heme, proteins circulating in the blood can bind the ion, reducing 
the concentration of free Fe3+ in the blood.  Some of these proteins are specifically designed to 
chelate and transport Fe3+, such as transferrin (Tf) [4, 6, 12, 13], while others such as albumin are 
general “workhorse” transport proteins capable of binding many entities [4, 6].  If the plasma 
proteins are unavailable for binding Fe3+, the free metal can be complexed by small molecules in 
the blood plasma such as citrate and free amino acids [4, 14].   
 
An additional word should be said regarding the role of transferrin.  Transferrin is a small (80 
kDa) glycoprotein ordinarily found in the blood and cerebrospinal fluid whose role is to chelate 
and transport Fe3+ to tissues where it is needed [3, 15].  It is internalized by endocytosis and 
releases Fe3+ in the low-pH endosome before being excreted for another round of Fe3+ transport 
[3].  Because the pH of the blood, CSF and interstitial fluid is approximately neutral (pH 7.4) [16], 
Fe3+ is unlikely to be released in an uncontrolled manner in healthy hosts.  These fluids are 
normally sterile.  However, fluids which can contact the air (such as tears, saliva, bile and breast 
milk) utilize a different iron transport protein.  These fluids tend to have a lower pH than blood 
[1] and also may encounter bacteria.  An iron transport protein that releases Fe3+ under acidic 
conditions would encourage bacterial growth in these fluids, so the protein lactoferrin (Lf) is 
used to bring iron to cells in contact with these fluids [4, 6, 9, 11, 13].  Lactoferrin does not release 
Fe3+ under acidic conditions and therefore can traffic Fe3+ to epithelial tissues without making 
the iron available to bacteria or fungi that may be present near these tissues [4, 9, 10, 12, 14].    
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2.3.2  Infection Response Pathways  
Should an infection establish itself in the body, the liver responds to inflammatory cytokines [9] 
by producing the peptide hormone hepcidin [4, 6, 9, 10, 12].  Hepcidin suppresses the production of 
ferroportin, a cation transport protein used to bring Fe3+ into the cytosol [4, 12].  Ferroportin 
production is particularly suppressed in cells lining the GI tract, reducing iron absorption from 
the diet [12].   
 
Bacteria tend to acidify tissues they infect (mainly to generate the proton gradient necessary for 
oxidative phosphorylation), so any Fe3+ in the area bound by transferrin (Tf) will be released to 
solution and thus made available to the pathogens.  Therefore, empty lactoferrin is trafficked to 
the infected or inflamed site to scavenge any free Fe3+ in the area [4, 10-13]. 
2.4 Bacterial Response to Iron Sequestration  
Bacteria have evolved many mechanisms to scavenge iron from their environment, whether that 
environment is a human host or a matrix such as soil.  These mechanisms include lysing 
erythrocytes to internalize and degrade hemoglobin [6, 10, 13], internalizing and degrading Fe-
transferrin and Fe-lactoferrin [4, 10, 11, 13], lowering the pH of their environment to promote Fe3+ 
dissociation from Tf [10, 12], and siderophore production [4, 6, 9-11, 13].  This last pathway is 
interesting from a chemical and molecular imaging perspective.     
2.4.1  The Siderophore Pathway  
Siderophores are small molecules synthesized and excreted by bacteria (and some fungi) to 
harvest Fe3+ from their environment [4, 6, 9-11, 13] (figure 2-2).  They bind Fe3+ with extremely high 
affinity (binding constants on the order of ~1050 [14, 17]) but bind Fe2+ poorly, if at all.   
 
 20 
 
 
Figure 2-2: Representative siderophore structures: a) staphyloferrin A, b) pyochelin, c) DFO 
After complexing Fe3+, the Fe-siderophore complex diffuses in the blood or interstitial fluid until 
it encounters a bacterium expressing a particular surface receptor to which it can bind.  After 
binding to the surface receptor, the Fe3+ in the siderophore is internalized by a strain-specific 
mechanism.  Generalized schema for both Gram-positive and Gram-negative bacteria are shown 
in figure 2-3, below.   
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Figure 2-3:  Siderophore uptake mechanisms in Gram-positive (left) and Gram-negative (right) bacteria [4] 
In bacteria utilizing the siderophore pathway, the siderophores and receptors for the Fe-
siderophore complex are constitutively produced in small amounts [4, 6, 9-11, 13].  Lack of iron in 
their environment de-represses the Fur operon, which is responsible for siderophore and receptor 
production.  The bacterium then produces and secretes relatively large quantities of its 
siderophore(s) [4, 6, 9-11, 13].      
2.4.2  Previous Medical Uses of Siderophores  
Perhaps the most common use of siderophores is chelation therapy [4, 6, 12], in which 
siderophores’ affinity for Fe3+ is exploited to remove Fe3+ from the blood.  Patients with 
excessively high blood Fe3+ concentrations are given the apo-siderophore desferrioxamine (DFO; 
figure 2-4) intravenously.  The apo-DFO complexes any free Fe3+ in the blood and is excreted 
through the kidneys[18, 19] .  Patients benefitting from chelation therapy include people with 
hereditary iron-overload disorders (such as β-thalassemia) [4, 6] and transfusion dependent 
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patients [20].  Patients given chelation therapy have been shown to have lower infection loads than 
untreated patients, whose blood iron levels are higher [4, 6].   
 
Figure 2-4:  DFO-B, used in chelation therapy [17] 
Siderophores have the potential to be molecular imaging agents.  They bind specifically to their 
target (particular species of bacteria), they are selectively taken up even at tracer concentrations 
and they have the capacity to be modified to be tracked via non-invasive methods.  These aspects 
will be further explored in Chapter 3, in which the most effective way to convert siderophores 
into molecular imaging tracers is examined.   
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 Chapter 3: Siderophores as Molecular 
Imaging Agents  
When constructing a molecular imaging tracer, it is important to ensure the imaging beacon and 
targeting moiety are compatible.  In the case of PET tracers, one must consider the decay 
characteristics of the radionuclide, including half-life, β+ decay fraction, and the energy and type 
of other decay modes.  The chemical behavior of the radionuclide must be such that the tracer 
atom may be easily and stably incorporated into the tracer without significantly altering the in 
vivo behavior of the tracer [1].  In order to generate images of medical utility, the radionuclide 
must remain with the tracer until the tracer reaches its target, preferably until the intact tracer is 
cleared from the body [1].   
3.1 Isotopes to Consider 
Several radionuclides have characteristics that make them suitable candidates for radiolabeling 
siderophores.  They are all radiometals with chemistry similar to iron, enabling the siderophores 
to be radiolabeled via a simple complexation reaction.  Radiolabeling procedures of this type are 
simpler, require less technical expertise to perform and reduce radiation dose to personnel 
compared to the multi-step organic radiosynthetic techniques often used to incorporate 
radioactive atoms into a molecule’s backbone, such as in the radiosynthesis of [18F]FDG [2].  
Three radionuclides that could be fruitfully used to radiolabel siderophores are 52Fe, 68Ga and 
89Zr.   
3.1.1 52Fe  
   Because 52Fe (t1/2=8.3 h, avg Eβ+= 1.9 MeV 
[3]) is an isotope of iron, it should behave 
approximately identically to the natFe3+ that siderophores chelate so selectively[1].  Therefore, 
52Fe-siderophore complexes will theoretically be taken up in exactly the same manner and at 
essentially the same rate as the non-tracer natFe-siderophores.  However, because many proteins 
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in the human body also bind Fe3+ and several actually remove Fe3+ from Fe-siderophores (e.g., 
the lipocalins [4]), the presence of 52Fe at a site in the body might not necessarily indicate the 
presence of 52Fe-siderophores at that site.  The observed PET signal could be due to host proteins 
sequestering 52Fe transchelated from the injected tracer and therefore be of little clinical use, as 
the signal might not indicate localization of disease.  Additionally, this nuclide is produced via 
the 55Mn(p,4n)52Fe reaction [5, 6], which requires a large accelerator to accelerate protons to 
sufficient energy (~50 MeV) [6].  There are many competing reaction channels and the cross 
section for production of 52Fe is small.  For all these reasons, the use of 52Fe has not been 
pursued in this work.           
3.1.2 68Ga 
Access to 68Ga (t1/2= 68 min, avg Eβ+=0.846 MeV 
[7]) is much simpler than 52Fe, since 68Ge/68Ga 
generators are commercially available [8].  These generators typically consist of an ion exchange 
column to which the parent nuclide (68Ge) is nearly permanently bound [1, 9-11].  When the parent 
decays to the daughter, the daughter has a much lower affinity for the column material and can 
be eluted with a suitable solvent.  The eluted daughter can then be used for additional 
radiochemical procedures.[1].  Generators are simple to operate, but they are relatively costly as 
they must be wholly replaced when the parent material is depleted.   
 
In addition to greater availability, 68Ga has the advantage of having chemistry similar to that of 
Fe [12, 13].  Molecules that complex Fe3+ well (such as transferrin [8]) tend to complex Ga3+ readily, 
so the siderophore imaging literature has focused on68Ga-labeled siderophores[14-17].  Ga has been 
shown to have antimicrobial activity [12, 18, 19], so theoretically a 68Ga-siderophore tracer could be 
used to localize an infection as well as show exactly where a natGa-siderophore (which would 
specifically deliver cytotoxic doses of the metal to the infection site) would be taken up.   
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3.1.3  89Zr   
89Zr (t1/2=3.3 d, Avg Eβ+=0.9 MeV (22.7%) 
[20]) is an intriguing choice of radiometal for 
transforming siderophores into PET tracers.  While its chemistry is not as close to that of iron as 
68Ga, 89Zr does behave very similarly to iron [13] and therefore siderophores will likely complex 
89Zr readily.  Its half-life is much longer than the biological half-lives of small molecules, but it 
is likely to form very stable complexes, enabling the activity to be cleared from the body with the 
tracer, thereby lowering radiation dose to the patient.  It can be produced in high specific activity 
on ordinary biomedical cyclotrons [21], allowing for wider use of the nuclide than 52Fe.  However, 
it emits an additional γ ray (0.91 MeV, 99%)[20] with each decay besides the 511 keV positron 
peak, giving rise to dosimetry concerns for both patients and personnel.       
 
89Zr was chosen as an initial isotope for use in investigating siderophores as PET tracers, due to 
its availability, ease of production and novelty as a signal for siderophore imaging. 
3.1 Zirconium 
3.2.1  Chemistry  
Zirconium is a second row transition metal with a chemistry similar to that of iron.  Its most 
common oxidation state is Zr(IV) and it tends to form octavalent (or higher coordinate) 
complexes [13].  Zr4+ is a very hard acidic cation [8] and thus strongly complexes with hard base 
ligands, particularly those containing N- and O- donors [8, 13].  Many of these complexes, such as 
Zr-desferrioxamine (Zr-DFO), are kinetically inert to demetallation [22].   
The chemical literature for Zirconium focuses on the element’s coordination chemistry [23-25], 
metallurgy (Zr is used as an alloying agent in steel, as well as cladding for fuel in nuclear 
reactors) [1, 26-28], on zirconium-containing materials for medical devices [29-31], and on zirconium 
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complexes as components of chromatographic resin for separations of metal ions [32, 33], peptides 
[34], and small molecules [35]. 
3.2.2  Biological Role  
While the metallurgical and strictly inorganic characteristics of Zr have been heavily investigated 
(see above), its behavior in living systems has been poorly characterized.  The element has no 
known biological role [36, 37] and transport into any type of cell has never been shown.  The 
adsorption of free Zr to the surface of fungal spores [38], yeast spores [39] and Citrobacter [40] has 
been demonstrated and characterized in bulk.  This adsorption has been shown to depend on pH 
[41, 42].  However, there are no reports of transport of Zr into the cytosol of these potentially 
infectious cell types.  A search of several major databases (PubMed, Web of Science, Science 
Direct) found only one publication discussing Zr uptake by any sort of infection [43].    
3.2.2 Radiochemistry  
Since 89Zr decays via positron emission, its location in a system may be ascertained by Positron 
Emission Tomography (PET).  Its fairly low-energy positrons (Eβ=0.9 (22.7%) and 2.4 (0.2%) 
MeV [20]) allow high-resolution images to be obtained in vivo.   However, reports of PET 
imaging using 89Zr-based tracers have used very large molecular moieties, such as monoclonal 
antibodies or other large proteins [44].  These tracers are imported into the cell to which they bind.   
Because 89Zr is biologically inert, it must be attached to these tracers via a suitable bifunctional 
chelator.  The monoclonal antibodies used to target the HER2 receptor [44], Fibroblast activation 
protein (overexpressed in Rheumatoid arthritis patients) [45], Prostate-specific antigen [32] and 
other biological targets [44] do not chelate 89Zr4+ on their own.  The chelator most commonly used 
is 1-(4-Isothiocyanatophenyl)-3-[6,17-dihyroxy-7,10,18,21-tetraoxo-27- [N-
acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane]thiourea (DFO-NCS), an activated 
derivative of desferrioxamine (DFO) [32].  DFO is a highly useful chelator: its Zr coordination 
 28 
 
chemistry is well-characterized, it completes quantitatively (when in present above tracer 
concentrations) and the  Zr complex is relatively stable in vivo [32].  If DFO is modified by the 
addition of a benzyl isothiocyanate group, it can be easily conjugated to targeting moieties with 
free amine groups, such as lysines [32].    
3.3 Siderophore Library 
The 89Zr complexation efficiency and bacterial uptake behavior of a library of synthetic 
siderophores were examined.  These siderophores were derived from danoxamine (fig. 3-1), a 
natural product produced by Streptomyces violaceus (DSM 8286) [46, 47].  Danoxamine is the 
iron-binding portion of the salmycin antibiotics these bacteria secrete [47].  While it does not 
directly have anti-microbial activity, it ensures the specific uptake of salmycin antibiotics by 
particular microbes.   
Members of the library were previously synthesized by systematically modifying the 
succinyl terminus of danoxamine with a variety of functional groups and variously-sized spacers 
in order to probe the effect of pKa, stereochemistry, ligand identity and hydrogen bonding ability 
on the ability of danoxamine to coordinate and complex metal ions [46].   
The iron chemistry of the resulting library has already been thoroughly investigated [46, 48].  
However, the zirconium chemistry of these compounds and uptake behavior as Zr complexes is 
unknown.   
3.4 Scope of this Work 
This work investigates the possibility of using 89Zr-labeled siderophores as molecular imaging 
agents for infection identification, as well as examining the conditions under which optimal 
effective specific activity may be obtained for 64Cu.     
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Because work with radiometals often requires extreme attention to the presence of contaminating 
metal ions, Chapter 4 presents a thorough investigation of a complexation assay used to 
determine the effective specific activity of 64Cu and proposes concrete suggestions for obtaining 
precise, accurate and high ESA values when producing and using this radiometal.  Chapter 5 
explores the Zr chemistry of a library of danoxamine-derived siderophores and the specificity of 
their uptake by a variety of bacterial species.  Chapter 6 discusses the implications of these 
results and explores future directions this research could take.   
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Chapter 4: Sources of metal contamination 
and specific activity measurement variations  
in cyclotron produced 64Cu  
 
 
 
 
NB: This work is currently out for review at Applied Radiation and Isotopes as “Sources of metal contamination and 
specific activity measurement variations in cyclotron produced 64Cu” Nora C. Goscinski, Tara Mastren, Paul 
Eisenbeis, Efrem Mebrahtu, Suzanne E. Lapi. 
 
High effective specific activity (ESA) of 64Cu is important for high-efficiency radiolabeling with 
this radiometal, but the sources of metal contaminants that can interfere with radiolabeling are 
not fully known.  Additionally, accurate determination of this parameter is important for 
determining batch purity and the TETA titration, a common method for finding 64Cu ESA, has 
not been fully characterized.  The purpose of this study was twofold, firstly to identify sources of 
metal contaminants in the 64Cu production process and secondly to identify metals that interfere 
with the binding of 64Cu to the TETA chelator. Possible sources of contamination at all stages of 
the 64Cu production process were identified. The Cu2+-TETA complexation reaction was 
characterized for repeatability and interferences, and the interfering metal profiles of a variety of 
reaction vessels and reagents were quantified.  Our results indicate that the TETA titration 
method for determining 64Cu ESA has both relative standard deviations of 27.6% and 40.3% for 
repeatability and reproducibility respectively and the chelator TETA is selective for picomolar 
amounts of Cu2+ in the presence of low millimolar concentrations of Zn2+ and Ni2+.   
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4.1 Introduction 
4.1.1 64Cu Specific Activity and Sources of Contamination 
The positron-emitting metal 64Cu is emerging as an important radionuclide for Positron Emission 
Tomography (PET) and has been incorporated into radiopharmaceuticals for imaging a variety of 
targets such as hypoxia [1-3], amyloid-β plaques [4,5] and numerous targets on cancer cells [6-9].  
Producing this isotope in high specific activity is important for efficient radiolabeling and for the 
production of high specific activity radiopharmaceuticals for imaging of low abundance targets.  
Additionally, accurately determining the effective specific activity (ESA, radioactivity per µmol 
of competing metal ions) of 64Cu is necessary as the presence of other metals in 64Cu may 
decrease the radiochemical yield of a radiolabeling procedure.  However, in selecting a method 
for determining the ESA of a radiometal, it is important to consider the chemistry of the final 
radiolabeling procedure.  A quality control assay that is less selective than the chemistry to be 
performed will give a falsely-low ESA value for the radiometal, while a QC procedure that is far 
more selective could return a high ESA value that underestimates the effects of interfering 
species in the final radiolabeling reaction.  
 Cold metal contaminants may enter cyclotron-produced 64Cu at many points during the 
production process.  Reagents used to prepare the 64Ni target may contain non-Ni metal atoms.  
Trace amounts of dissolved metals in target cooling water could be deposited on the target 
backing and inadvertently mixed with 64Cu during target processing.  Additionally, the reagents 
and resin used for post-bombardment processing may not be metal-free, and incomplete 
separation of 64Cu and 64Ni may occur.  Trace amounts of cold metals could leach from the 
containers into which 64Cu is dispensed and stored.  The reagents and vessels used for the TETA 
titration itself may contain sufficient levels of extractable cold metals to interfere with 
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complexation of Cu by the chelator.  Finally, sample manipulation during target transfer, 
dispensing and the TETA titration requires exposure to potential airborne metals.  
4.1.2 ESA Determination 
There are many methods of determining ESA of 64Cu, including ion chromatography [10], liquid 
chromatography-mass spectrometry [11] and titration of Cu2+ with a selective chelator, most 
typically 1,4,8,11-tetraazacyclotetradecane-1,4,8, 11-tetraacetic acid (TETA) [10, 12, 13].  TETA is 
considered selective for Cu2+ because the binding constant (log K value) for Cu2+-TETA (log 
K=21.7) [14,15] is larger than the log K values for Ni2+-TETA (19.9) [14,15], or Zn2+-TETA (log 
K=16.4) [14,15].  (All log K values refer to the 𝑀 + 𝐿 ↔ 𝑀𝐿 equilibrium, where L is the 
completely deprotonated chelator.)  The TETA titration method is a popular method for 
determining 64Cu ESA, but the assay itself has never been fully characterized as a method.  
Additionally, while the effect of metal ions on the formation of other complexes, such as 68Ga-
DOTA [16-18], 68Ga-NOTA [17-18] and 68Ga-DTPA [18] has been thoroughly examined, no such 
analysis has been done for the formation of 64Cu-TETA in the presence of other metal ions.  
4.1.3  Sources of Error   
The goal of characterizing an assay is to determine the reliability of the results it returns.  Some 
of the aspects typically examined include the assay’s repeatability (precision when the same 
sample is analyzed multiple times by a single analyst), reproducibility (precision when the same 
sample is analyzed by different analysts), and robustness (precision and accuracy in the presence 
of chemical contaminants or slight variations in experimental conditions), including the method’s 
selectivity for the analyte in the presence of similar substances [19].   
Potential sources of error in the TETA titration method of determining  64Cu ESA include a 
chelator that is either more or less selective than the chelator used in radiolabeling, a protocol 
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that is inherently low-throughput and vulnerable to human error, and the presence of other metals 
in the reaction from a variety of sources.    
All of the above sources of metal contamination and error in the 64Cu-TETA complexation 
method were examined.  The TETA titration was independently performed by two analysts for 
17 batches of 64Cu.  The extractable metal content for a variety of vessel types and reagents was 
profiled and quantified.  The effects of Ni2+ and Zn2+ on Cu2+-TETA complexation were 
examined by spiking in the cold metals at a variety of concentrations and comparing the resulting 
ESA to the ESA of pure (as received) 64Cu.  Additionally, the repeatability and reproducibility of 
the TETA titration results were examined and the metal content of the materials used in 64Cu 
production and final 64Cu production batches were profiled and quantified by ion 
chromatography.   
4.2 Materials and Methods 
4.2.1 Materials 
All chemicals were trace-metal grade and used as received unless otherwise noted.  In-house 
milliQ water (18 MΩ-cm) was used to prepare solutions unless otherwise noted.  1,4,8,11-
tetraazacyclotetradecane-1,4,8, 11-tetraacetic acid (TETA) was purchased from Macrocyclics 
(Dallas, TX).   
Ammonium acetate, ammonium sulfate, methanol (reagent grade), TraceSelect Ultra water, 
TraceCERT atomic absorption spectroscopy standards (1000 mg/L Fe3+, Cu2+, Ni2+, Zn2+ ,Co2+ in 
nitric acid), and ethylenediaminetetraacetic acid (EDTA) were purchased from Sigma Aldrich 
(St. Louis, MO).  Glass-backed silica thin layer chromatography plates (silica gel 60 F-254) were 
purchased from EMD Millipore (Billerica, MA).  Nitric acid, 96-well plates (polystyrene), 
 37 
 
screwcap microcentrifuge tubes (virgin polypropylene, polypropylene screwcap with O-ring), 
snaptop microcentrifuge tubes (high clarity polypropylene, DNase/RNase-free, pyrogen-free), 5 
mL Polyvials for ASDV autosampler with plain caps, and 15 and 50 mL conical centrifuge tubes 
(polypropylene, non-pyrogenic), were obtained from Fisher Scientific (Waltham, MA).  
Polystyrene 96-well plates were also purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA).  Ethanol (absolute) was purchased from DeCon Labs (King of Prussia, PA).  Concentrated 
PDCA eluent (35 mM pyridine-2,6-dicarboxylic acid, 330 mM KOH, 28 mM K2SO4, 370 mM 
formic acid), solid 4-(2-pyridylazo)resorcinol (PAR), and PAR diluent (1.0 M 2-
dimethylaminoethanol, 0.50 M NH4OH, 0.30 M NaHCO3) were purchased from Dionex 
(Sunnyvale, CA) and diluted to working concentrations with milliQ water and PAR diluent, 
respectively.  5 mL (6 mL) Norm-Ject Luer-Lock syringes (polypropylene, pyrogen-free, sterile) 
were purchased from Henke-Sass-Wolf (Tuttlingen, Germany) and used as received for manual 
injections for ion chromatography.  Target cooling water was sampled from the CS-15 cyclotron 
and stored in polypropylene syringes before analysis.  64Cu (as 64CuCl2) was produced in-house 
using an automated module [21].  Concentrated sulfuric acid (99.9999% metals basis) and NH4OH 
(99.99% metals basis) were purchased from Alfa Aesar (Ward Hill, MA).     
4.2.2 Instrumentation 
A high performance liquid chromatography unit consisting of a Dionex ICS-3000 HPLC with a 1 
mL sample loop, a GP50 pump, an AD20 absorbance detector, an AS-DV autosampler and a 
column heater (Thermo Scientific) was used for ion chromatography analysis.  An IonPac CS5A 
analytical column was used with an IonPac CG5A guard column (Dionex) to separate metals 
extracted from vessels and reagents.  The post-column reagent PAR (0.06 g/L) was delivered 
using pressurized helium via a PC10 pneumatic controller (Dionex).  For manual injections, the 
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sample was injected onto the column using a 5 mL Norm-Ject syringe.  When the AS-DV 
autosampler was used to deliver sample to the column, EDTA- and acid-washed polyvials were 
used.  A CRC-25R dose calibrator (Capintec, Ramsey NJ) was used for all activity 
measurements.  TLC plates were analyzed for activity with a RadioTLC plate reader (Bioscan, 
Washington DC).  
4.2.3  Acid Washing  
Strict acid-washing protocols were followed to ensure that reaction and storage vessels had 
minimal extractable metal contents.  Unless otherwise noted, vessels for use in the TETA 
titration were acid washed as follows: complete immersion in 1:1 concentrated nitric acid: milliQ 
H2O for ≥4 hours followed by a rinse with absolute ethanol.  They were then dried overnight in 
an oven (37⁰C).  The acid-washed vessels were closed and stored in screw-top jars (subjected to 
the same acid-washing protocol) until use.  The polyvials used by the ASDV autosampler 
required a more rigorous metal-extraction procedure before use: the vials and caps were rinsed 
with milliQ H2O, soaked in 1 M EDTA (alkalinized with solid NaOH until all EDTA dissolved) 
for at least 48 hours and again rinsed with milliQ H2O before immersion in a 1:1 HNO3:H2O 
bath (described above) for a minimum of 48 hours.  The autosampler vials and caps were stored 
in the acid bath until use, when they were rinsed with milliQ H2O before being filled with 
sample.  In an attempt to reduce sample contamination, ion chromatography samples were 
prepared immediately before analysis.     
4.2.4  TETA Titration  
The TETA titration was performed as previously described[12, 13].  Briefly, 7.4 MBq (200 µCi, 20 
µL) 64Cu were added to a series of vials or wells in a 96-well plate containing 8 different 
concentrations of TETA (in 0.1 M NH4OAc buffer, pH 5.5) and enough 0.1 M NH4OAc to bring 
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the volume to 80 µL.  The solutions were placed on a shaking incubator and incubated for 60 
minutes at 80 ⁰C.  The percent 64Cu complexation was determined via radioTLC: 1 µL aliquots 
from each solution were spotted on TLC plates and developed in 1:1 MeOH: 10% NH4OAc (pH 
5.5).  Developed plates were placed on a RadioTLC plate reader for analysis.  For interference 
analysis, 40 µL Ni2+ or Zn2+ was added to the reaction before 64Cu; the volume of 0.1 M 
NH4OAc was reduced accordingly.    
4.2.5  Metal Profiles  
Samples were prepared by heating 0.1 M NH4OAc at 80 ⁰C for 1 hour (as per the TETA titration 
protocol) in a variety of reaction vessels.  The heated NH4OAc was then diluted (1:200) with 
milliQ water (for autosampler runs) or UltraTrace water (for manual injections).  The samples 
were separated and quantified as previously described [10].  Briefly, a 1 mL injection loop was 
used to load samples onto the analytical column, PDCA eluent was pumped through the column 
at 0.3 mL/minute and a post-column mixing loop was used to mix metals eluting from the 
column with 4-(2-pyridylazo)resorcinol, which complexed metal ions in effluent.  The 
concentration of the metal-PAR complex was monitored via UV at 530 nm.   
4.2.6 Analysis  
Data were analyzed using Prism (Graphpad, CA).  Selectivity coefficients were calculated using 
an arbitrary low number of mols of Cu (1𝑥10−12 mols) for comparison, as the concentration of 
Cu2+ ions in received 64Cu was typically below the detection limit of ion chromatography.  
4.3 Results 
4.3.1 Reproducibility and Repeatability 
For the 17 64Cu production batches tested, the difference between ESA values obtained by 
different analysts was significant (P=0.0196 for Analyst 1 vs Analyst 2).  ESA values determined 
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using TETA titration obtained by a single analyst for a single batch of 64Cu was variable and 
ranged from 0.9 % to 27.6%. (Analyst 2 error bars, figure 4-1).   
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Figure 4-1:  Effective specific activity of 64Cu as determined by complexation with TETA.  ESA’s before 7/17/13 
were determined using acid-washed polypropylene vials.  ESAs on or after 7/17/13 were determined using 
polystyrene 96 well plates. 
The ESA of 64Cu increases with batch size (R=0.390) and this effect is statistically significant.  
However, batch size does not seem to affect the precision of the TETA assay, as the correlation 
between batch size and the standard error of the mean is not statistically significant.  The 
variation in Cu-TETA complexation behavior (seen in the size of the standard error of the mean 
ESA) is likely inherent to the complexation reaction itself, because more-precise ESA values are 
not obtained for production batches with higher concentrations of 64Cu.   
4.3.2  Selectivity of TETA for Cu2+ 
To verify the selectivity of TETA for Cu2+ in the presence of large excesses of other divalent 
first-row transition metal ions, Zn2+ and Ni2+ were spiked into the TETA titration at a variety of 
concentrations, the effect on 64Cu ESA was determined, and the selectivity coefficients of TETA 
for Cu2+ in the presence of the contaminants were calculated.  A value of Kanalyte interferent between 
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+1 and -1 indicates that the method is more selective for the analyte than the interferent [19].  
When the interferences of Zn2+ and Ni2+ with Cu
2+-TETA complexation were examined, KCu, Zn 
was found to be 8.34𝑥10−4 while KCu. Ni was 4.62𝑥10−3, indicating that while TETA is highly 
selective for Cu2+,  Ni2+ is more likely to interfere with Cu2+ complexation than Zn2+.   
Ni2+ was spiked into the Cu-TETA complexation reaction to achieve final Ni2+ concentrations 
ranging from 1.7 to 204 µM (figure 4-2; for clarity, only the lowest spike concentrations are 
shown).  As expected, the presence of Ni2+ lowered the ESA of 64Cu.  When the difference in 
ESA caused by the spike was normalized to the unspiked 64Cu ESA, the interference increased 
linearly with Ni2+ concentration.  At spike concentrations below 2.25 µM, ESA variation can no 
longer be ascribed to the presence of spiked-in Ni2+, as the error bars for Ni2+-spiked and 
unspiked 64Cu ESA’s overlap below this concentration.   
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Figure 4-2:  Effect of Ni2+ spike on 64Cu ESA 
Zn2+ interference was determined by spiking Cu-TETA complexation reaction at a variety of 
concentrations, from 2.75 to 183.5 µM (figure 4-3).  The presence of Zn2+ lowered the ESA of 
64Cu at all but the lowest concentration tested (2.75 µM, figure 4-3).  At spike concentrations 
below 5.1 µM, the error bars for spiked and unspiked 64Cu-TETA complexation reactions 
overlap; therefore, Zn2+ is no longer the sole cause of ESA variation below 5.1 µM.   
 42 
 
[Z n ] (u M )
E
S
A
 (
m
C
i/
u
m
o
l 
m
e
ta
l)
0 1 0 2 0 3 0 4 0 5 0
0
2 .01 0 4
4 .01 0 4
6 .01 0 4
8 .01 0 4
E S A  (m C i/u m o l m e ta l)
U n s p ik e d  E S A
(m C i/u m o l m e ta l)
 
Figure 4-3:  Effect of Zn2+ spike on 64Cu ESA 
4.3.3  Sources of Interference: Metal content of vessels, reagents and 64Cu 
Labeling buffer (0.1 M NH4OAc) was heated in a variety of reaction vessels made of different 
types of plastic to determine extractable metal content.  The vessels were incubated as received 
and after acid-washing.  The metal content of the labeling buffer after incubation was determined 
via ion chromatography.  Unheated labeling buffer and other reagents were also analyzed.   
The labeling buffer was essentially metal free when prepared with milliQ water, with the 
exception of Zn2+, which is present at levels below those found in all reaction vessels (table 4-1).  
Polystyrene 96-well plates (as received) have the lowest extractable metal levels of all vessels 
tested.   
Acid-washing increased the Zn2+ content of molecular biology grade (DNase/RNase-free) 
snaptop tubes nearly 9x, despite the use of trace metal grade HNO3.  Trace metal grade HNO3 
was found to contain approximately 7 µM Zn2+ (table 4-1), suggesting that direct transfer of Zn2+ 
from the acid bath to tubes is unlikely.  It is possible the acid had time to loosen but not 
completely liberate Zn2+ from the polypropylene matrix.  However, acid washing appears to 
lower the levels of extractable Cu2+ and Zn2+ in polypropylene screwtop tubes, suggesting that 
different grades of polypropylene contain different concentrations of Zn2+.  
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Table 4-1:  Metal concentrations (µM) in TETA reaction mixture due to leaching from reaction vessel 
*’Premium’ vials were molecular biology grade. 
Quantification of the metal profiles of 64Cu production batches after decay found no significant 
correlation between total metal content and ESA (figure 4-4).  Additionally, cold metals were 
found to be present at millimolar concentrations (table 4-2) while the TETA titration indicates 
that Cu2+ is present at picomolar concentrations in CuOAc, so TETA is still highly selective for 
Cu2+.   
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Figure 4-4: Effect of total metal content on precision of 64Cu ESA 
Metal 0.1 M 
NH4OAc 
(pH 5.5) 
HNO3 96 well plate 
(as received) 
Screwtop vials 
(as received) 
Screwtop 
Vials (acid-
washed) 
‘premium’ Snaptop 
Vials* (as received) 
‘premium’ Snaptop 
Vials* (acid washed) 
Fe3+ < blank < 
blank 
< blank < blank < blank 
<blank <quant limit 
Cu2+ < blank 0.37 0.75 0.43 < blank 0.72 0.82 
Ni2+ < blank < 
blank 
< blank <blank < blank 
<blank <quant limit 
Zn2+ 0.38 7.20 0.55 68.35 11.37 7.31 67.91 
Co2+ Not 
detected 
<blank Not detected <blank < quant limit 
Not detected <quant limit 
[TETA] 
(well 5, 
~EC50) 
0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Plastic 
Type 
--- -- Polystyrene Polypropylene Polypropylene High clarity 
Polypropylene 
High clarity 
Polypropylene 
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Table 4-2:  Metal profiles of selected 64Cu production batches 
 
4.3.4  Sources of interference:  Metal content of cyclotron target cooling 
water and separation reagents  
It has been noted [13] that target cooling water can be a source of cold metal contaminants in 
cyclotron-produced 64Cu.  Therefore, the metal content of cyclotron target cooling water was 
examined via ion chromatography over several 64Cu productions.  The total metal content of the 
target cooling water tracks with 64Cu ESA—higher ESA is seen for batches with high metal 
concentrations in the cooling water and a major drop in ESA is seen when metal content of 
cooling water drops (due to water change-out; figure 4-5).  However, the exact cause of this 
relationship remains undetermined.  
Metal 
(µM) 6/18/2013 6/26/2013 7/2/2013 7/9/2013 7/16/2013 7/23/2013 7/30/2013 
Fe3+  1085 -- -- -- -- -- -- 
Cu2+  -- -- -- -- 16 -- -- 
Ni2+  2096 2794 2488 5486 1874 11416 5435 
Zn2+  4023 8932 29214 -- 5231 5583 33344 
Co2+ -- -- -- -- -- -- -- 
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Figure 4-5:  Effect of CS-15 target cooling water metal content on 64Cu ESA 
 
The resin and acid solutions used in target processing were also analyzed for metal content via 
ion chromatography (table 4-3).  When treated with 6 M HCl, unused AG1-X8 anion exchange 
resin was found to have high levels of extractable Zn2+ (5604 μg/L) and Fe3+ (4136 μg/L), with 
smaller amounts of Cu2+ and Ni2+.  0.5 M HCl, used to elute purified 64Cu during target 
processing, had similarly high concentrations of Fe3+ and Zn2+.  However, after passage through 
a column of AG1-X8 resin, the 0.5 M HCl had no detectable Fe3+ and the Zn2+ content doubled 
to 10,959 μg/L.  The Ni content of the 0.5 M HCl increased from 744 μg/L to 1674 μg/L after 
passing through the resin, while the Cu2+ content remained fairly constant (1546 μg/L pre-, 1414 
μg/L post-column)  This suggests that AG1-X8 resin binds Zn2+ at high concentrations of HCl, 
but freely releases the metal when treated with 0.5 M HCl .  Thus, the resin used to separate 64Cu 
from the 64Ni target may be a major contributor to the cold metal contaminants found in 
cyclotron-produced 64Cu.   
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Table 4-3:  Metal profiles of reagents used in 64Cu separation 
Metal  (μg/L) 0.5 M HCl 6 M HCl passed 
through fresh resin Pre-column Post-column 
Fe3+ 3930 -- 4136 
Cu2+ 1546 1414 1546 
Ni2+ 744 1674 589 
Zn2+ 5943 10959 5604 
 
All the reagents used to prepare 64Ni targets contained Fe3+ (up to 2.87 mg/mL), while 
(NH4)2SO4 also contained Ni
2+ (1.59 mg/mL) and NH4OH contained Cu
2+ (2.04 mg/L).  Cobalt 
was not detected in any target processing reagents.   
4.4 Discussion 
When comparing ESA values for a single batch of 64Cu obtained by different analysts, the 
standard error of the mean ranged from 5.1% to 40.3% of the mean ESA, while the standard 
error for ESA values obtained by a single analyst ranged from 0.9% to 27.6% of the mean.  The 
repeatability and reproducibility of the assay appear to be batch dependent.  This may be due to 
the extremely low analyte concentration, as typical concentrations of 64Cu are in the picomolar 
range.  At such low concentrations, it may take a long time for the chelator and metal ion to form 
a complex and even tiny differences in reaction mixture composition or conditions can 
dramatically affect the kinetics of the complexation process.  Likely the thermodynamic product 
(64Cu2+-TETA) is formed after a long incubation at high temperature, but perhaps 60 minutes at 
80⁰C does not provide sufficient thermal energy to minimize the formation of kinetic products 
such as Ni2+-TETA or Zn2+-TETA.  Additionally, reaction pH may affect the affinity of a 
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chelator for various metal ions.  TETA was chosen for its high affinity for Cu2+ in its completely 
deprotonated form, but at pH 5.5, other, more-protonated forms of TETA may exist, each with its 
own set of stability constants.   
 
There is a positive correlation between 64Cu batch size and ESA of the 64Cu (R= 0.390).  A 
possible explanation for the increase in specific activity with increasing amounts of 64Cu 
produced is that the number of moles of cold interferents is essentially constant from batch to 
batch, since they are inherent to the production process.  Producing more activity would then 
lead to higher ESA values, since the number of 64Cu atoms increases compared to the constant 
number of interferent atoms.   
 
The Cu2+-TETA complexation reaction is perturbed by high concentrations of other metals in the 
reaction mixture.  The mean ESA of 64Cu spiked with contaminant metals is lower (2.3-69.7% 
lower) than the unspiked ESA for all production batches assayed.  The macrocycle TETA does 
complex Cu2+ with high selectivity, as indicated by complete complexation of 64Cu 
(approximately picomolar) by only picomoles of TETA in the presence of micromoles of cold 
Ni2+ and Zn2+, as well as by selectivity coefficient (for Cu2+) values much less than one.  
However, the vast excess of cold Ni2+ and Zn2+ ions in the reaction vessel likely leads to their 
complexation by TETA, giving rise to lower ESA values for 64Cu.   
 
Cold Ni2+ and Zn2+ in the 64Cu come from a number of sources.  Incomplete recovery of the 64Ni 
target material is likely a source of cold Ni2+ which is present as the main contaminant.  Cold 
Zn2+ found in AG1-X8 resin itself may co-elute with 64Cu during target processing.  
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Alternatively, the resin may concentrate cold Zn2+ from the target, plastics and solvents, then 
release it in the same fraction as 64Cu.  Additionally, many common plastic vessels contain 
significant amounts of extractable, interfering metal ions even after acid-washing.  Polystyrene 
was found to have the lowest amount of extractable metals, though polypropylene could also be 
nearly metal-free.  The initial TETA titration assay was performed in virgin polypropylene vials 
containing large quantities of extractable metals, and the ESA values obtained with these vials 
are consistently lower than those obtained in other vessels.  The use of polystyrene 96 well plates 
to run the TETA complexation reaction gave consistently higher ESA values for 64Cu than 
polypropylene vials and is inherently higher-throughput.   
 
In order to obtain more accurate ESA values for batches of 64Cu, we recommend running the 
TETA assay multiple times in parallel in polystyrene 96-well plates, using extremely high-purity 
metal-free reagents.  AG1-X8 resin used to separate 64Cu from 64Ni should be washed with 0.5 M 
HCl before use to remove cold metal ions.  If non-molecular-biology grade polypropylene is 
used to run the TETA assay or to store 64Cu, the vessels should be thoroughly soaked in trace-
metal grade acid to remove extractable metals from the plastic before use.  Careful manipulation 
of samples and vessels, with constant attention to the possibility of metal contamination, is also 
necessary to obtain high ESA and realistic ESA values and for subsequent high specific activity 
radiochemistry.   
4.5 Conclusion 
The Cu2+-TETA complexation assay has been characterized as a standard method.  It is 
perturbed by the presence of other first-row transition metal ions in the reaction mixture.  Ni2+ 
interferes with Cu-TETA complexation at spike concentrations below 2.25 µM, while Zn2+ 
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interferes with the assay at spike concentrations below 5.1 µM.  Sources of interfering metals 
include Ni2+ and other metal ions from the target, ion exchange resin used in target processing, 
and reaction vessel material with polystyrene and molecular biology grade polypropylene having 
the smallest amounts of extractable metal ions.  
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Chapter 5: 89Zr-siderophores as molecular 
imaging agents for bacterial infections  
 
Siderophores are small molecules synthesized by bacteria to harvest Fe3+ from their 
environment.  In infection scenarios, their production can increase infection virulence.  Their 
selective uptake in vivo in multi-bacteria environments indicates that this class of molecules has 
the potential to be selective imaging agents.  In this study, DFO-NCS and a library of 
trihydroxamate siderophores were evaluated as vehicles to deliver 89Zr selectively to bacteria for 
Positron Emission Tomography (PET) imaging of infections.  The uptake of 89Zr-DFO-NCS by 
human cells (SKBR3), Staphylococcus aureus, and Pseudomonas aeruginosa was significantly 
different (p<0.0001) and highest for S. aureus.  The Zr chemistry and bacterial uptake behavior 
of a library of trihydroxamate siderophores was evaluated and compared to that of DFO-NCS.  
Uptake of 89Zr-DFO-NCS and another siderophore library member (89Zr-V-129) were tested in a 
murine lung infection model (P. aeruginosa, PA M57-15) and 89Zr-V-129 was found to have 
significantly higher lung uptake in infected mice (p=0.0120) than in control mice. The uptake of 
89Zr-DFO-NCS did not differ significantly between control and infected mice (p=0.831).  89Zr-
siderophores have the potential to be selective, specific PET tracers for imaging bacterial 
infections in vivo and should be explored more thoroughly.     
5.1 Introduction 
 
Zirconium-89 is an emerging radiometal that has been successfully used to image a variety of 
diseases in vivo.  As discussed in section 3.2.1, 89Zr is biologically inert and must be attached to 
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molecular imaging tracers via a suitable bifunctional chelator.  The chelator most commonly 
used is 1-(4-Isothiocyanatophenyl)-3-[6,17-dihyroxy-7,10,18,21-tetraoxo-27- [N-
acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane]thiourea (DFO-NCS), an activated 
derivative of desferrioxamine (DFO) [1].  DFO is a highly useful chelator: its Zr coordination 
chemistry is well-characterized ,the reaction completes quantitatively (when in excess) and the  
Zr complex is relatively stable in vivo [1].  If DFO is modified by the addition of a benzyl 
isothiocyanate group, it can be easily conjugated to targeting moieties with free amine groups, 
such as lysines [1].   
 
However, 89Zr-DFO alone has the potential to target certain diseases, such as bacterial infections, 
as a small-molecule complex.  One area of current interest in the infection imaging community is 
the development of siderophore-based PET tracers.   
 
Because siderophores chelate Fe3+ so avidly, they can be radiolabeled with radiometals whose 
chemistry resembles that of Fe3+.  In fact, DFO is a siderophore, originally produced by 
Streptomyces pilosus [2, 3] and used clinically to lower the blood concentration of Fe3+ in patients 
with hereditary iron-overload disorders (such as β-thalassemia) [4, 5] and transfusion dependent 
patients [6] in addition to its use as a 89Zr chelator.   While the literature has previously focused 
on68Ga-labeled siderophores [7-10], 89Zr could also be used to transform a siderophore into an 
infection-targeted PET tracer.  While its chemistry is not as close to that of iron as 68Ga, 89Zr 
does behave very similarly to iron [11] and therefore siderophores with similar structures to DFO 
will likely complex 89Zr readily.  These 89Zr-siderophore complexes are likely to be quite 
kinetically stable, enabling the activity to be cleared from the body with the tracer, thereby 
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lowering patient radiation dose.  89Zr can be produced in high specific activity on a biomedical 
cyclotron equipped with a solid target station [12], allowing for widespread use.  Despite the many 
advantages 89Zr has to offer the PET chemist, it has been neglected in the arena of infection 
imaging.  A search of several major databases (PubMed, Web of Science, Science Direct) found 
only one publication discussing Zr uptake by any sort of infection [13].   
 
We present herein the first report of using 89Zr to image bacterial infections.  89Zr-DFO-NCS was 
characterized as a tracer for bacterial infections.  The 89Zr chemistry of a library of siderophores 
based upon DFO was explored (see figure 5-1 for selected structures): the complexation 
efficiency and stability towards demetallation of the 89Zr-siderophore complexes was examined 
and the complexes’ uptake by a panel of Gram-positive and Gram-negative bacteria was 
determined.  Finally, the efficacy of 89Zr-siderophores as tracers for imaging bacterial infections 
in vivo was tested by examining the uptake of 89Zr-DFO-NCS and the 89Zr complex of one 
siderophore (V-129) by Pseudomonas aeruginosa (PA M57-15) in a murine lung infection 
model. 
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Figure 5-1: Selected chelators used in this study 
  
5.2  Materials and Methods 
5.2.1  Materials 
All chemicals were reagent grade unless otherwise noted.  In-house milliQ water (18 MΩ) was 
used to prepare solutions unless otherwise noted.  1-(4-Isothiocyanatophenyl)-3-[6,17-dihyroxy-
7,10,18,21-tetraoxo-27-[N-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane]thiourea 
(DFO-NCS) was purchased from Macrocyclics, Inc (Dallas, TX).  HCl and NaOH were 
purchased from Fisher Scientific (Waltham, MA).  S. aureus (ATCC 11632) was provided by Dr. 
Tim Wencewicz (Washington University, St. Louis), while Pseudomonas aeruginosa cultures 
were provided by Dr. Steven Brody (Washington University, St. Louis).  SKBR3 cells were 
obtained from ATCC.  An incubator, culture tubes, inoculation loops and petri dishes were 
obtained from Fisher Scientific (Waltham, MA).  Agar was purchased from Lambda Biotech 
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(Ballwin, MO).  LB (Miller) powdered media, diethylenetriaminepentaacetic acid (DTPA), 
Deferoxamine mesylate (DFO), and 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
(HEPES) were obtained from Sigma Aldrich (St. Louis, MO).  Mannitol salt agar (MSA) was 
obtained from VWR International (Radnor, PA).  70% ethanol was prepared using 200 proof 
ethanol (in-house) and milliQ (18 MΩ-cm) H2O.  89Zr was produced in-house using an 
automated module [12] and was received as 89Zr-oxalate.   
5.2.2  89Zr Radiochemistry 
89Zr was neutralized in HEPES buffer (0.5 M, pH 7.1) and pH adjusted to 6.8-7.1 with NaOH 
and/or HCl.  Solid DFO-NCS was dissolved in DMSO (4-7 mg/mL) and diluted to 0.1 mg/mL in 
HEPES.  DFO-NCS and neutralized 89Zr were mixed to obtain an M:L ratio of 1:5, then 
incubated on a shaker (Eppendorf thermomixer, Fisher Scientific) at 37 ⁰C for 60 minutes.  The 
extent of 89Zr chelation was determined by TLC.  Briefly, 5 μL 50 mM DTPA (in milliQ H2O) 
were added to an aliquot of the 89Zr-DFO-NCS complexation mixture and incubated at 37 ⁰C 5 
minutes further before spotting on chromatography paper (CHR, Whatman, Pittsburgh, PA).  The 
strips were developed in 50 mM DTPA and analyzed for activity with a RadioTLC plate reader 
(Bioscan, Washington DC).  Likewise, siderophore library members were dissolved in water (1-2 
mg/mL), then diluted in HEPES buffer (0.5 M, pH 7.1) to a working concentration of 0.1 
mg/mL.  The siderophore working solution and neutralized 89Zr were then mixed (M:L ~1:5) and 
incubated on a shaker at 37 ⁰C.  For bacterial uptake studies, the siderophores were allowed to 
complex with 89Zr for 60 minutes.  For stability studies, aliquots were removed at various times 
and spotted on chromatography paper as above.  The TLC strips were developed and visualized 
as above. 
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5.2.3 Biological Assays 
Staphylococcus aureus and Pseudomonas aeruginosa were grown in a stationary incubator (37 
⁰C) for 18-24 hours in LB (Miller) broth.  500 μL aliquots of the cultures were incubated at 37 
⁰C with neutralized 89Zr or 89Zr-DFO-NCS (5 minutes, unless otherwise noted).  The cells were 
then centrifuged and washed twice with saline (0.9% NaCl) to remove non-specifically bound 
89Zr.  Pellet activity was then quantified with a dose calibrator (CRC-25R, Capintec, Ramsey 
NJ).  The incubation time, cell concentration, 89Zr/89Zr-DFO-NCS dose and concentration of 
Fe3+-depleting compounds in the media were all varied.  Internalization was determined by 
sonicating cell pellets (resuspended in sterile saline) for 5 minutes, followed by centrifugation.  
The activity present in cytosol (supernatant) and membrane (pellet) fractions was then measured.     
5.2.4 In vivo Studies 
A clinical isolate of P. aeruginosa designated PA M57-15 (1X105 CFU/30ul) was intra-trachealy 
instilled into mice (CD-1 white male, 6-8 weeks of age) one hour prior to imaging.   20 µg 
siderophore (V-129 or DFO-NCS) were incubated with 1 mCi 89Zr in HEPES (0.5 M, pH 7.1) at 
37°C for 1 hour, then diluted in saline. 70 – 90 µCi of the radiotracer was then injected into mice 
intratracheally instilled either with PA M57-15 bacteria in PBS or PBS only (negative control).  
Dynamic imaging was done for 0 – 40 min, followed by static imaging at 3 h post-injection.  At 
18 hours post-delivery of PA M57-15, the mice were euthanized for biodistribution studies. 
5.3  Results and Discussion 
5.3.1  89Zr-DFO as baseline siderophore: in vitro studies 
In order to determine whether chelation affects 89Zr uptake by bacterial cells, cultures of S. 
aureus were treated with free 89Zr (neutralized, but not otherwise manipulated) and with 89Zr-
DFO-NCS (90-130 μCi/tube).  After 5 minutes’ incubation at 37⁰, the cultures were centrifuged 
and the activity present in each wash fraction, as well as the initial supernatant and final pellet, 
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was quantified.  The vast majority of 89Zr remained in the media in both cases, but when chelated 
with DFO-NCS, up to 24.2% of 89Zr was found associated with S. aureus cells (figure 5-2a).  
(Note that the percentages of free 89Zr do not add up to 100%.  The difference was retained by 
pipet tips.)  Promisingly, unchelated 89Zr did not bind to or enter the bacterial cells at all.  
Because ‘free’ 89Zr is not taken up by bacterial cells, any 89Zr uptake observed in vivo will be 
from an intact 89Zr-siderophore, rather than a ‘lost’ ion of 89Zr.   
 
 
Figure 5-2: a) Effect of chelation on binding of 89Zr to S. aureus cells; b) selectivity of 89Zr-DFO-NCS uptake by 
mammalian cells, Gram-Positive bacteria (S. aureus) and Gram-negative bacteria (P. aeruginosa); and c) time-
dependence of 89Zr and 89Zr-DFO-NCS uptake by Gram-positive and Gram-negative bacteria 
 
The selectivity of 89Zr-DFO-NCS uptake was investigated by incubating model Gram-positive 
(S. aureus) and Gram-negative (P. aeruginosa) bacteria, as well as human cells (SKBR3), with 
89Zr-DFO-NCS as above.  S. aureus bound the highest fraction of 89Zr-DFO-NCS (58.8 ±6.9%), 
with P. aeruginosa binding significantly less (28.0±15.3%) and the mammalian cells binding 
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nearly none (3.0±0.7%) of the applied complex (figure 5-2b).  The extreme disparity between the 
fraction of 89Zr-DFO-NCS bound by bacterial cells and mammalian cells indicates that the 
complex may have the ability to selectively bind to/be taken up by bacterial cells in the presence 
of mammalian cells, such as in the context of an infection.  It also raises the possibility that 89Zr-
DFO-NCS may be a tracer well-suited to imaging bacterial infections in vivo, as there would be 
very little off-target (non-infection) uptake.  Additionally, the twofold higher uptake (p=0.0335) 
of 89Zr-DFO-NCS by S. aureus than by P. aeruginosa indicates that the complex is selectively 
taken up by Gram-positive bacteria.  This selectivity suggests the possibility of developing more-
targeted tracers (based on DFO-NCS) for identification of bacterial infections.    
 
To examine the effect of incubation length on 89Zr-DFO-NCS uptake by the two types of 
bacteria, cultures of both S. aureus and P. aeruginosa were treated with 5-10 μCi 89Zr 
(neutralized oxalate complex) or 89Zr-DFO-NCS and incubated at 37⁰C (stationary) for 
approximately 30 hours.  While no uptake of free radiometal by either strain of bacteria was seen 
at 60 minutes, by 28 hours post-labeling both S. aureus and P. aeruginosa showed slight uptake 
of free 89Zr (S. aureus: 1.7±1.3%, P. aeruginosa 7.7±6.0%).  As expected, uptake of 89Zr-DFO-
NCS was much higher than that of the free radiometal at both 90 minutes and 29 hours (figure 5-
2c).  Interestingly, at 90 minutes, P. aeruginosa had much higher cell-associated activity 
(16.1±14.4% vs 6.2±6.1% for S. aureus), whereas after 29 hours, S. aureus once more bound the 
majority of the complex.  Because very short (5-10 min) and very long (29 h) incubation periods 
result in higher selectivity of 89Zr-DFO-NCS for S. aureus than intermediate time points, the 
temporal aspect of bacterial uptake experiments with this complex should be carefully planned.   
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When the uptake behaviors of unfunctionalized DFO and DFO-NCS were compared, only the 
activated chelator was taken up (figure 5-3), while uptake of unfunctionalized DFO was 
negligible.  While this could indicate that DFO-NCS binds covalently to free amine groups on 
cellular surfaces, the specificity of its uptake suggests that the story is more complex.  When the 
uptake of 64Cu-NOTA-NCS by the panel of bacteria was examined, all of the strains tested took 
up a negligible amount of the NOTA-NCS complex.  Because 64Cu-NOTA-NCS is essentially 
not taken up while 89Zr-DFO-NCS is avidly taken up, the role of NCS in siderophore uptake is 
likely more complex than simply serving to covalently anchor the siderophore complex to the 
outer bacterial membrane.   
 
 
Figure 5-3: Effect of p-Bn-SCN group on uptake of 89Zr-DFO by S. aureus, P aeruginosa and E coli. 
 
5.3.2  Behavior of Siderophore Library 
Of the siderophores examined, only 89Zr-III-116, 89Zr-IV-27, 89Zr-V-144, 89Zr-V-129 and 89Zr-
V-143 were taken up by any of the bacteria tested (figure 5-4a-b).  While 89Zr-DFO-NCS was 
taken up to varying extents by all bacteria tested (figure 5-4a), 89Zr-V-144 was only taken up by 
Fe3+-deprived S. aureus (p<0.0001), indicating that 89Zr-V-144 may select for Gram-positive 
organisms under infection-like conditions (figure 5-4b). Iron-starved E. coli took up over 10x 
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more 89Zr-V-143 than Fe3+-deprived S. aureus (p=0.00057), indicating that 89Zr-V-143 may 
select for Gram-negative organisms.  89Zr-siderophore uptake is specific to bacterial type, growth 
conditions and the siderophore itself, indicating that finding a siderophore avidly taken up by a 
given bacterium may require testing a large library of compounds.   
 
 
 
 
 
 
 
 
 
Figure 5-4: Uptake of 89Zr-siderophore complexes by Gram-positive and Gram-negative bacteria grown under a) 
iron-replete conditions, b) iron-deficient conditions. 
 
5.3.3 In vivo Studies  
When 89Zr-DFO-NCS and 89Zr-V-129 were administered to mice with P. aeruginosa lung 
infections, different clearance routes were observed for 89Zr-V-129 and 89Zr-DFO-NCS.  89Zr-
DFO-NCS cleared through the kidneys as expected [14, 15] , while the 89Zr-V-129 complex 
undergoing hepatobiliary clearance (figure 5-5c).  When the lung uptake of infected and control 
(uninfected) mice was examined, the uptake of 89Zr-V-129 was significantly higher (p=0.012) in 
infected mice at early timepoints (12.5-32.5 minutes; figure 5-5a).  For 89Zr-DFO-NCS, the 
difference in lung uptake between infected and control mice was not significant (p=0.83; figure 
5-5b).  At the extended timepoint of the biodistribution study (>17 h post-injection), the lung 
uptake of neither tracer was significantly different between infected and healthy mice (figure 5-
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5d).  However, the difference in lung uptake seen 12.5-32.5 minutes post-injection for 89Zr-V-
129 is promising and shows that 89Zr-siderophores could be used as tracers for infection imaging.  
Structural optimization is likely required to find a siderophore/bacteria combination with 
enhanced uptake differences in vivo.  Further studies are warranted to determine the optimal 
siderophore structures for PET imaging of various types of infections.   
 
Figure 5-5: : a) time-activity curve for 89Zr-V-129 in vivo; b) time-activity curve for 89Zr-DFO-NCS in vivo; c) in 
vivo uptake of 89Zr-DFO-NCS and 89Zr-V-129 (static scan, 3 hr post-injection); d) biodistribution of 89Zr-DFO-NCS 
and 89Zr-V-129 in mice (sacrificed 17 h post-injection) 
 
5.4  Conclusion 
The complex 89Zr-DFO-NCS has been validated as a radiotracer for bacteria.  The complex is 
selective for Gram-positive bacteria, but can be taken up slightly by the Gram-negative 
Pseudomonas aeruginosa.  Siderophores based on DFO are also selectively taken up by bacterial 
cells in vitro and in vivo and therefore have the potential to be novel PET tracers when chelating 
89Zr.   
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5.6  Supplementary Information 
 
Figure 5-6: a) effect of varying cell (S. aureus and P. aeruginosa) concentration on uptake of 10 μCi 89Zr-DFO -
NCS; b) effect of varying 89Zr-DFO-NCS dose on tracer uptake by S. aureus and P. aeruginosa 
 
Neat cultures of S. aureus and P. aeruginosa were spiked with 0 to 30 μCi 89Zr-DFO-NCS in 
order to study the effect of dose on tracer fraction bound.  The highest fraction of 89Zr-DFO-NCS 
was found to stick when 5-10 μCi were administered to 500 μL culture.  However, the total 
amount of activity bound to each cell pellet was so small in this range that internalization studies 
could not be performed with a dose calibrator.  Consequently, 20 μCi/500 μL culture was 
selected as the standard dose.   
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Chapter 6: Concluding Remarks 
 
Radionuclides have the potential to reveal reams of information about living systems, 
information that cannot be easily obtained via other techniques.  In particular, nuclei that emit 
positrons can be incorporated into molecules in order to track the movement of the molecule 
within a living system via PET imaging.  Radiometals have the potential to probe systems which 
move too slowly for the shorter-lived organic radioisotopes (18F, 11C) as well as systems in which 
the movement of a particular metal is of interest.  However, before a radiometal-radiotracer 
combination can be fruitfully used to investigate biological questions, the radiochemistry of the 
nuclide itself as well as the radiotracer as a whole must be thoroughly understood.   
6.1 Efficacy of TETA Titration at Determining Effective 
Specific Activity of 64Cu 
The Cu2+-TETA complexation assay has been characterized as a standard method.  It is 
perturbed by the presence of other first-row transition metal ions in the reaction mixture.  Ni2+ 
interferes with Cu-TETA complexation at spike concentrations below 2.25 µM, while Zn2+ 
interferes with the assay at spike concentrations below 5.1 µM.  Sources of interfering metals 
include Ni2+ and other metal ions from the target, ion exchange resin used in target processing, 
and reaction vessel material with polystyrene and molecular biology grade polypropylene having 
the smallest amounts of extractable metal ions.   
 
Thoroughly understanding the intimate details of assays used to determine effective specific 
activity of radiometals and other radionuclides is necessary for these materials to be used 
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rationally.  While the TETA titration assay is a useful tool for rapid determination of the quality 
of a 64Cu batch, it is conducted on tracer-concentration material and therefore the presence of 
contaminants several orders of concentration above the analyte will perturb the assay.  However, 
these contaminants will also affect the radiolabeling chemistry performed by the final user of the 
64Cu.  Therefore, care should be taken to eliminate or minimize the presence of contaminating 
metal ions in production reagents and materials, storage vessels and containers for radiolabeling 
when working with radiometals, particularly 64Cu.   
6.2 Viability of 89Zr-siderophores as Tracers for PET 
Imaging of Bacterial Infections 
DFO-NCS, a well-established chelator for 89Zr, has been characterized as a targeting moiety in 
itself when complexing 89Zr.  89Zr-desferrixoamine and other 89Zr-radiolabled trihydroxamate 
siderophore chelators have been shown to target bacterial cells in vitro.  While their activity 
towards bacteria when complexed with Fe3+ is well-characterized, these compounds retain their 
affinity for bacteria when complexed with 89Zr4+.  Compounds in a small library of siderophores 
were examined for stability of 89Zr chelation and affinity for various Gram-positive and Gram-
negative bacteria.  Uptake specificity of these compounds varied: 89Zr-DFO-NCS was taken up 
to varying extents by all bacteria tested, while some 89Zr-siderophore complexes were not taken 
up by any of the strains, by only a fraction of the species or only when the bacteria were deprived 
of Fe3+.  The variations in uptake behavior indicate that 89Zr-siderophores have the potential to 
be tracers that specifically identify living bacterial cells.  
 
In vivo studies validated in vitro results. 89Zr-siderophores can be selectively taken up by 
bacterial infection in vivo and tracer uptake is not seen in uninfected animals.  While the results 
 66 
 
are not dramatic, tracer uptake in the area of infection (lung) was significantly higher in infected 
than in control mice.  However, this increased uptake was only true for one of the two tracers 
tested, indicating that a given strain of bacteria will potentially only take up certain 89Zr-
siderophores.  Additional investigations in this area could lead to the identification of tracer-
bacterial pairs giving clinicians a powerful tool to confirm diagnoses, monitor infection 
dynamics and determine appropriate courses of treatment for individual patients. 
6.3 Future Directions 
89Zr-siderophores could be used in the future as radiotracers to image bacterial infections in vivo 
via PET.  However, these tracers must be thoroughly investigated in order to find the optimal 
tracer to use for a given infection type before human imaging studies can begin.  In the course of 
this future investigation, methods will need to be validated, models confirmed and results 
verified.  The development of 89Zr-siderophores as PET tracers for bacterial infections promises 
to be an interesting and fruitful endeavor with implications for personalized medicine.   
For the correct tracer/ pathogen combination to be fruitfully used to investigate biological 
questions, the radiochemistry of the nuclide itself as well as the radiotracer as a whole must be 
thoroughly understood.   
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